Publicacions
-
Bayona C; Alza L; Randelovic T; Sallán MC; Visa A; Cantí C; Ochoa I; Oliván S; Herreros J
Tetralol derivative NNC-55-0396 targets hypoxic cells in the glioblastoma microenvironment: an organ-on-chip approach.
CELL DEATH & DISEASE 15 127-127. .
-
Alza, L; Visa, A; Herreros, J; Canti, C
T-type channels in cancer cells: Driving in reverse.
Cell Calcium 105 102610-102610. .
-
Visa, A; Alza, L; Canti, C; Herreros, J
Tetralol derivative NNC-55-0396 induces glioblastoma cell death by activating IRE1a, JNK1 and calcium signaling.
BIOMEDICINE & PHARMACOTHERAPY 149 112881-112881. .
-
Visa, A; Alza, L; Casas-Benito, A; Herreros, J; Canti, C
Targeting T-type channels in cancer: what is on and what is off?
DRUG DISCOVERY TODAY 27 743-758. .
-
Alza, L; Nàger M; Visa, A; Canti, C; Herreros, J
FAK Inhibition Induces Glioblastoma Cell Senescence-Like State through p62 and p27.
Cancers 12 -. .
-
Alza, L; Visa, A; Herreros, J; Canti, C
The rise of T-type channels in melanoma progression and chemotherapeutic resistance.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER 1873 188364-188364. .
-
Visa, A; Shaikh, S; Alza, L; Herreros, J; Canti, C
The Hard-To-Close Window of T-Type Calcium Channels
Trends in molecular medicine 25 571-584. .
Projectes
- Ajuts al Talent en Investigació Biomèdica 2023 - 11a Edició
- Targeting calcium channels against primary and resistant glioblastoma